Taken together, the results with Drosophila provide additional insight into possible mechanisms for the anti-obesity and anti-diabetes effects of mifepristone observed in mice and humans, including the potential implication of Dhr96-related factors such as VDR and LXRa. This evidence concerns the gene NR1H3 and diabetes mellitus.